Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research : Workshop Summary, PDF eBook

Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research : Workshop Summary PDF

Edited by Adam C. Berger, Steve Olson

PDF

Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.

Information

Other Formats

Information